GEISINGER WYOMING VALLEY MED CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $267K
- Transactions
- 102
- Companies
- 15
- Average per transaction
- $2,617
Who reported the payments
| AstraZeneca | $87,612 |
| Insulet Corporation | $64,169 |
| Astrazeneca UK Limited | $59,910 |
| Incyte Corporation | $23,549 |
| Medtronic | $7,405 |
| Acell, Inc. | $6,038 |
| MIVI Neuroscience, Inc. | $5,213 |
| Stryker | $2,759 |
| Inpeco North America, Inc | $2,442 |
| Linvatec Corporation | $2,383 |
| Medline Industries LP | $2,000 |
| KARL Storz Endoscopy-america | $1,890 |
| CSL Behring | $1,128 |
| Medical Graphics Corporation | $410 |
| Amgen | $5 |